| Literature DB >> 27157393 |
Hongliang Duan1, Daleep Arora1, Yu Li2, Hendra Setiadi1, Depeng Xu1, Hui-Ying Lim3, Weidong Wang4.
Abstract
The <span class="Gene">C/EBP-homologous protein (<span class="Gene">CHOP) acts as a mediator of endoplasmic reticulum (ER) stress-induced pancreatic insulin-producing β cell death, a key element in the pathogenesis of diabetes. Chemicals that inhibit the expression of CHOP might therefore protect β cells from ER stress-induced apoptosis and prevent or ameliorate diabetes. Here, we used high-throughput screening to identify a series of 1,2,3-triazole amide derivatives that inhibit ER stress-induced CHOP-luciferase reporter activity. Our SAR studies indicate that compounds with an N,1-diphenyl-5-methyl-1H-1,2,3-triazole-4-carboxamide backbone potently protect β cell against ER stress. Several representative compounds inhibit ER stress-induced up-regulation of CHOP mRNA and protein, without affecting the basal level of CHOP expression. We further show that a 1,2,3-triazole derivative 4e protects β cell function and survival against ER stress in a CHOP-dependent fashion, as it is inactive in CHOP-deficient β cells. Finally, we show that 4e significantly lowers blood glucose levels and increases concomitant β cell survival and number in a streptozotocin-induced diabetic mouse model. Identification of small molecule inhibitors of CHOP expression that prevent ER stress-induced β cell dysfunction and death may provide a new modality for the treatment of diabetes.Entities:
Keywords: Anti-diabetic drug; Beta cell death; Beta cell survival; CHOP; Diabetes; ER stress
Mesh:
Substances:
Year: 2016 PMID: 27157393 PMCID: PMC5176337 DOI: 10.1016/j.bmc.2016.03.057
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641